Carbon-ion radiotherapy for Cholangiocarcinoma: A multi-institutional study by the Japan Carbon-ion radiation oncology group (J-CROS)
Not Applicable
- Conditions
- Cholangiocarcinoma
- Registration Number
- JPRN-UMIN000035565
- Lead Sponsor
- Gunma University Heavy Ion Medical center
- Brief Summary
The median survival was 14.8 (range, 2.1-129.2) months, and the 1- and 2-year OS rates were 69.7% and 40.9%, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
1) previous treatment for the target tumor by other radiation therapies or surgery; 2) tumor invasion of the digestive tract; 3) an untreatable ascites; 4) other active malignant tumors besides the cholangiocarcinoma to be treated; 5) severe comorbidity such as uncontrolled diabetes mellitus, renal failure, or cardiac failure; 6) a serious medical or psychological condition precluding safe administration of treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method